Molecular Markers for the Prediction of Progression of CIN Lesions

International Journal of Gynecological Pathology

Volumn 23, Issue 2, 2004, Pages 95-96

  Gray, Lindsey J ^a   Herrington, C Simon ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 13; CYTOKERATIN 14; INVOLUCRIN; KI 67 ANTIGEN; MOLECULAR MARKER; PROTEIN E6; PROTEIN E7; PROTEIN P16; RETINOBLASTOMA PROTEIN; VIRUS PROTEIN;

CANCER GROWTH; CELL CYCLE; EDITORIAL; FEMALE; HUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CARCINOGENESIS; VIRUS INFECTION; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; DISEASE PROGRESSION; FEMALE; HUMANS; NEOPLASM INVASIVENESS; ONCOGENE PROTEINS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR MARKERS, BIOLOGICAL; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 1642353195     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-200404000-00001     Document Type: Editorial

References (15)

1. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958-64.
2. Walboomers M, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:1-3.
3. Fehrmann F, Laimins LA. Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation. Oncogene 2003;22:5201-7.
4. Southern SA, Herrington CS. Disruption of cell cycle control by human papillomaviruses with special reference to cervical carcinoma. Int J Gynecol Cancer 2000;10:263-74.
5. Klaes R, Benner A, Friedrich T, et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002;26:1389-99.
6. Keating JT, Cviko A, Riethdorf S, et al. Ki67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papillomavirus-related cervical neoplasia. Am J Surg Pathol 2001;25:884-91.
7. Shiozawa T, Shiohara S, Kanai M, et al. Expression of the cell cycle regulator p27 (Kip1) in normal squamous epithelium, cervical intraepithelial neoplasia, and invasive squamous cell carcinoma of the uterine cervix. Immunohistochemistry and functional aspects of p27 (Kip1). Cancer 2001;92:3005-11.
8. Keafing JT, Ince T, Crum CP. Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis. Adv Anat Pathol 2001;8:83-92.
9. von Knebel Doeberitz M. New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer 2002;38:2229-42.
10. Kruse AJ, Skaland I, Janssen EA, et al. Quantitative molecular parameters to identify low and high risk early CIN lesions: role of markers of proliferative activity and differentiation and Rb availability. Int J Gynecol Pathol 2004;23:100-109.
11. Kruse AJ, Baak JP, Janssen EA, et al. Low and high risk CIN1 and 2 lesions: prospective predictive value of grade, HPV, and Ki67 immunoquantitative variables. J Pathol 2003;199:462-70.
12. Duensing S, Munger K. The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Cancer Res 2003;62:7075-82.
13. Herrington CS, Graham D, Southern SA, et al. Loss of retinoblastoma protein expression is frequent in small cell neuroendocrine carcinoma of the cervix and is unrelated to HPV type. Hum Pathol 1999;30:906-10.
14. Jones DL, Alani RM, Munger K. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev 1997;11:2101-11.
15. Southern SA, McDicken IW, Herrington CS. Loss of cytokeratin 14 expression is related to human papillomavirus type and lesion grade in squamous intraepithelial lesions of the cervix. Hum Pathol 2001;32:1351-5.